Murine models demonstrated that anti PD-1 therapy exerted antitumour effect on MHC-I−MHC-II+ tumours in a cytotoxic CD4+ T cell-dependent manner, while the same effect on MHC-I−MHC-II− tumours was not reached [88]. Here, CD4 is linked to neoplasm.